CROI 2015 Program and Abstracts

Disclosure Information

Cysique, Lucette Self: ViiV Healthcare: Grants/grants pending; AbbVie: Grants/grants pending; MSD: Grants/grants pending; AbbVie: Payment for development of education presentations De Groote, Mary Self: SomaLogic, Inc.: Consulting or advisor fee Spouse/partner: SomaLogic, Inc: Employment Dicker, Ira Self: Bristol Myers Squibb: Employment Dore, Gregory Self: Gilead, AbbVie, Merck, Bristol-Myers Squibb, Janssen: Board Membership; Gilead, AbbVie, Merck, Bristol-Myers Squibb, Janssen: Grants/grants pending; Gilead, Merck, Roche, Janssen: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Gilead, AbbVie, Merck, Bristol-Myers Squibb: Other Doyle, Tomas Self: ViiV Healthcare: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus; Merck Sharpe & Dohme: Other: Merck Sharp and Dohme funded the study Eckard, Allison Self: GSK, BMS, Cubist Pharmaceuticals: Grants/grants pending; Gilead: Consulting or advisor fee; Other: data safety monitoring board section Edén, Arvid Self: Gilead, AbbVie, BMS, Roche: Other: travel grants; coauthor Dr Gisslén: lecture honoraria. Elion, Richard Self: Gilead Sciences, Merck,VIV, Jansen: Grants/grants pending; Gilead Sciences: ExpertTestimony; Gilead Sciences, VIV, Merck, Jansen, BMS: Grants/grants pending; Gilead Sciences,ViiV, BMS : Consulting or advisor fee Institution: WhitmanWalker Health: Gilead Sciences: Grants/grants pending Ferretti, Francesca Institution: San Raffaele Scientific Institute: Bristol Meyer Squibb: Grants/grants pending Fordyce, Marshall Self: Gilead Sciences, Inc.: Employment Foster, Rosalind Self: Other: Research Funding Galli, Laura San Raffaele Scientific Institute: Bristol-Myers Squibb: Grants/grants pending Gandhi, Monica Self: Other: Gilead Sciences (South San Francisco, CA) providedTDF/FTC in iPrEX OLE but had no other role in study design, data accrual and analysis, or abstract preparation. Gange, Stephen Self: Merck, Inc.: Fees for participation in the review activities, eg, data monitoring boards, statistical analysis, or end point adjudication committees German, Polina Self: Gilead Sciences, Inc.: Employment; Stock/stock options

Gibb, Diana Institution: University College London:ViiV Healthcare, Merck, Gilead, CIPLA for supply of drugs for clinical trials: Provision of medicines, equipment, or administrative support Golden, Matthew Self: Melinta Pharmaceuticals: Grants/grants pending Gottlieb, Geoffrey Self: AlereTechnologies, GmbH: Grants/grants pending; Gilead Sciences, Inc: Grants/grants pending; BMGF: Grants/ grants pending; UptoDate: Royalties; Monogram Biosciences: Grants/grants pending; Abbott: Provision of medicines, equipment, or administrative support Grant, Robert Self: Gilead Sciences: Provision of medicines, equipment, or administrative support;ViiV: Grants/grants pending; Siemens: Consulting or advisor fee Grinspoon, Steven Self: Theratechnologies: Consulting or advisor fee; Navidea: Consulting or advisor fee; Novo Nordisk: Consulting or advisor fee; Astra Zeneca: Consulting or advisor fee Institution: Amgen: Grants/grants pending; Grants/grants pending;Theratechnologies: Grants/grants pending; Bristol- Myers Squibb: Grants/grants pending Grulich, Andrew Self: ViiV, Gilead: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus Gupta, Samir Self: JanssenTherapeutics: Grants/grants pending; Gilead Sciences: Grants/grants pending; Merck & Co: Grants/grants pending Hakim, James Self: Mylan Pharmaceuticals: Board Membership Ham, Anthony Self: ImQuest BioSciences: Stock/stock options Institution: NIH: Grants office: Grants/grants pending Spouse/partner: ImQuest BioSciences: Employment Hamzah, Lisa Self: Janssen-Cilag: Payment for development of education presentations; Gilead Sciences: Lisa Hamzah has received funding from Gilead Sciences to attend a conference. Coauthor Frank A. Post has received funding to attend conferences or educational meetings, honoraria and/or research funding from AbbVie, Gilead Sciences, Bristol-Myers Squibb, Janssen-Cilag, GlaxoSmithKline/ViiV Healthcare and Merck Hill, Andrew Self: Janssen: Consulting or advisor fee; Diego Ripamonti: Consulting or advisor fee; Ralph DeMasi: Employment; Ceyhun Bicer: Employment; Christiane Moecklinghoff: Employment; Graham Cooke: Gilead: Consulting or advisor fee Ho, Emily Self: Santa Cruz Biotechnology, Inc.: Royalties Huang, Wei Self: Monogram Biosciences: Employment Huang, Yunda Self: Bionor Pharma ASA: Consulting or advisor fee

Hullegie, Sebastian Institution: Erasmus MC: Merck, Gilead: Grants/grants pending Hunt, Peter Self: Consulting or advisor fee; Bristol Myers Squibb: Consulting or advisor fee; Gilead: Consulting or advisor fee; Gilead: Payment for development of education presentations; Janssen: Payment for development of education presentations;Tobira: Consulting or advisor fee Ingiliz, Patrick Self: Gilead: Board Membership; AbbVie: Board Membership; Janssen-Cilag: Payment for development of education presentations; BMS: Payment directly from commercial firms for lecture(s), including service on speakers’bureaus Jain, Vivek Self: Gilead Sciences: Grants/grants pending Jeffrey, Jerry Self: GSK: Employment Kim, Arthur Self: Bristol-Myers Squibb: Consulting or advisor fee; AbbVie: Consulting or advisor fee Institution: Massachusetts General Hospital: AbbVie: Grants/grants pending; Gilead Sciences: Grants/grants pending Klein, Marina Self: GlaxoSmithKline/ViiV: Consulting or advisor fee; Merck: Grants/grants pending; Schering-Plough: Grants/ grants pending; Bristol-Myers Squibb: Grants/grants pending; Gilead: Payment for development of education presentations; GlaxoSmithKline/ViiV: Payment for development of education presentations Klevens, Monina Self: CDC Foundation: Provision of medicines, equipment, or administrative support; Other: Data purchase from Quest and administrative support to analyze data were funded with a grant from the CDC Foundation which currently receives a grant from AbbVie Kohli, Payal Self: Amgen: Consulting or advisor fee; Pfizer: Consulting or advisor fee; Summer Street Research: Consulting or advisor fee Kooij, Katherine Self: Gilead Sciences: Other:Through my institution I have received a travel grant to attend a scientific conference from Gilead Sciences Koss, Catherine Institution: University of California, San Francisco: AbbVie Pharmaceuticals: Provision of medicines, equipment, or administrative support; Other: AbbVie Pharmaceuticals (North Chicago, Illinois) provided lopinavir/ritonavir (Aluvia) but had no other role in study design, data accrual and analysis, or abstract preparation Kostman, Jay Self: AbbVie: Consulting or advisor fee Krakower, Douglas Self: Gilead Sciences: Grants/grants pending; Bristol-Myers Squibb: Grants/grants pending; Medscape: Payment for development of education presentations

Disclosure Information

653

CROI 2015